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Antifungal compoundThe morbidity, mortality and economic burden associated with fungal infections, together with the emer-
gence of fungal strains resistant to current antimicrobial agents, necessitate broadening our understanding
of fungal pathogenesis and discovering new agents to treat these infections. Using invertebrate hosts, espe-
cially the nematode Caenorhabditis elegans and the model insects Drosophila melanogaster and Galleria
mellonella, could help achieve these goals. The evolutionary conservation of several aspects of the innate im-
mune response between invertebrates and mammals makes the use of these simple hosts an effective and
fast screening method for identifying fungal virulence factors and testing potential antifungal compounds.
The purpose of this review is to compare several model hosts that have been used in experimental mycology
to-date and to describe their different characteristics and contribution to the study of fungal virulence and
the detection of compounds with antifungal properties. This article is part of a Special Issue entitled: Animal
Models of Disease.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
In recent years, systemic fungal disease incidence has rapidly
increased, especially in immunocompromised patients [1]. This
presents a signiﬁcant problem, as these diseases are associated with
high mortality (ranging from 40 to 67% for candidiasis and over 88%
for invasive aspergillosis) [2,3], and new fungal strains resistant to
multiple antifungal agents are being encountered in the ICU setting
[4]. These facts underscore the need to better understand the patho-
physiology of different fungal infections, which could help reveal
new targets of drug therapy and lead to the development of new an-
tifungal agents.
The murine model is one of the most commonly used models for
studying fungal infection because of the similarity of murine and
humanphysiology and immune systems. However, ethical and logistical
constraints associatedwith theuse ofmice in such experiments slow the
evolution of our understanding in the ﬁeld of mycology, which must
progress more rapidly if we wish to hinder the ever-growing resistance
of fungal pathogens to antimicrobial compounds.
This emerging need for an easier and faster method of in vivo exper-
iments on fungal pathogenesis can be addressed by using invertebrate
model hosts. Many studies have shown that, although invertebrates
are separated bymillions of years of evolution frommammals,many as-
pects of the innate immune system are conserved between the speciesl Models of Disease.
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l rights reserved.[5]. Additionally, their low cost, simplicity of use and short life span
make invertebrates ideal candidates for large-scale studies. Finally,
there are no ethical constraints in the use of invertebrates, which fur-
ther facilitates their use for in vivo experimentation. The purpose of
this review is to elucidate the characteristics of different invertebrate
model hosts that have been used to study fungal diseases, as well as
the relative advantages and potential drawbacks associated with each.
2. Drosophila melanogaster
Since the groundbreaking discovery by Lemaitre et al. [6] that the
Toll pathway serves an essential role in Drosophila defense against
pathogenic fungi, accompanied by the widely reproduced ﬁgure of
dead Toll-deﬁcient ﬂies covered by Aspergillus fumigatus hyphae, the
fruit-ﬂy has been used widely in experiments of fungal pathogenesis.
The sequencing of its whole genome [7], the creation of RNAi libraries
[8] that permit selective deactivation of speciﬁc genes, and the availabil-
ity of mutant strains facilitate studies of different aspects of its immune
response to fungal pathogens. For example, two main pathways of
microbial resistance in the fruit ﬂy have been described. The Imd path-
way appears to be more important against Gram-negative bacteria,
while the immune reaction against Gram-positive bacteria and fungi
follows a different pathway, the Toll/Spätzle pathway [9]. Speciﬁcally,
as reviewed elsewhere [10,11], fungal invasion is recognized via pattern
recognition receptors,most importantly GNBP-3,which recognizes fun-
gal beta-glucans and triggers a reaction leading to the processing of a
small molecule, called Spätzle, which functions as the ligand of the
Toll receptor. The activation of the Toll pathway leads in turn, through
the recruitment of proteins like MyD88 and the transcription factor
NF-kB, to the release of molecules with potent antifungal activity called
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immune system seems to be capable of recognizing elements of
fungal virulence and triggering the Toll pathway via another protease,
called Persephone, independent of the GNBP-3 mechanism [14]. This
microbial-speciﬁc response seems to apply to systemic infections, while
in epithelial infections the Imd pathway seems to coordinate Drosophila
defense [15–17]. Newer studies have also shown the importance of path-
ways not related to either Toll or Imd in the immune response of the fruit
ﬂy, like the JNK and the JAK/STAT pathways [18]. Further, Chen et al.
showed that the p38 pathway that is part of the Toll cascade inmammals
participates in the immune response of Drosophila independent of the
Toll pathway, by up-regulating the expression of heat-shock proteins
and suppressing JNK activity [19]. It is important to note, however, that
despite similarities in the innate immune response between the fruit
ﬂy and humans, there are many differences that pose serious limitations
to themodel. First,Drosophila does not have an adaptive immune system
and lacks antibodies. Additionally, its innate immune system lacks natu-
ral killer cells, dendritic cells and cytokines that play a crucial role in the
human immune response. Finally, the fruit ﬂy cannot be easily used as a
model system for tissue-speciﬁc infections in humans.
Despite these technical limitations, Drosophila ﬂies have been
used as an experimental model for fungal virulence factors and in
studies that aim to identify novel antifungal compounds. For these
purposes Toll-deﬁcient ﬂies are used, as wild-type ﬂies are resistant
to most types of fungal infection. For example, studies have shown
that, as in mammals, hyphal formation is an important virulence
factor for Candida infection in ﬂies [20], though the Cryptococcus
neoformans main virulence factor in mammals–capsule formation–
does not seem to play an equally important role in the Drosophila
model [21]. Lionakis et al. have developed a protocol for the testing
of several antifungal compounds in a Drosophilamodel of invasive as-
pergillosis [22]. The administration of antifungal compounds in ﬂies
can happen either orally or via direct injection of the compound,
however the latter requires special equipment and expertise [10].
Interestingly, a novel study by Glittenberg et al. provides insight
into how wild-type Drosophila strains can be used to study Candida
virulence, thus expanding the model and potentially making it more
relevant to mammals [23]. Different researchers have recently pro-
vided evidence that, while wild-type Drosophila ﬂies cannot be killed
by Candida glabrata, they also cannot completely eliminate the infec-
tion as C. glabrata cells can remain viable inside the insect's phago-
cytes, just as occurs in mammals [24]. Finally, a method that utilizes
Drosophila hemocyte-derived S2 cells has been used as an alternative
approach to study fungal virulence and host–pathogen interactions.
In one study, researchers showed that white Candida albicans cells
are more susceptible to phagocytosis by host hemocytes than opaque
C. albicans cells, thus suggesting that a change from white to opaque
cell type might help the fungus evade immune detection [25]. In an-
other study, investigators utilized Drosophila S2 cells and RNA in-
terference and found 57 host genes that play an important role in
C. neoformans infection including genes associated with autophagy
[26]. In both of these studies, results were validated by comparison
to results obtained using murine macrophages.
In summary, D. melanogaster is a promising model for the study of
host immune response, pathogen virulence factors, and efﬁcacy of anti-
microbial compounds in fungal diseases. Its main limitations are that it
requires special lab equipment (e.g. a “ﬂy room” and incubators) and
technical expertise in handling the ﬂies [27].
3. Caenorhabditis elegans
Since its ﬁrst use in neurobiology and genetics by S. Brenner in the
1960s, the nematode C. elegans has gained much popularity as an in
vivo model for a variety of infectious disease and immunological
studies. Some properties that make it a favorable model are its rapid
life cycle, its physiological simplicity, the production of geneticallyidentical progeny (self-fertilizing hermaphrodite), the transparency
of its cuticle that permits direct observation of processes that go on
inside the nematode, and its easy obtainability. Additionally, it has a
fully sequenced genome and an easy process of RNA interference
has been developed to silence speciﬁc genes on demand [28]. The
nematode is usually grown on lawns of Escherichia coli OP50, which
is its natural food source, and then it is placed on lawns of fungi for
infection to occur [29]. This process does not allow for the precise cal-
culation of inoculum, as it is impossible to predict how much each
worm will eat. Due to its very small size, however, direct injection
of the fungus into the nematode is not practical.
In 2002, Kim et al. showed that an essential step in C. elegans im-
mune response against pathogens requires a MAP kinase signaling
cassette which is the homologue of p38 MAP kinase found in mam-
mals [30]. Additionally, it was later found that the nematode also
has a TIR domain protein (TIR-1) that functions as a homologue to
the human SARM protein and positively regulates the antimicrobial
peptides NLP-31 and NLP-29 [31,32]. Finally, by infecting C. elegans
nematodes with the fungus Drechmeria coniospora and subsequently
analyzing nematode protein and gene expression, it was found that
a chaperone of the BiP/GRP78 family of proteins, called hsp-3, func-
tions upstream of the TIR-1 protein to activate the cascade leading
to NLP-29 expression [33,34]. These homologous proteins are further
examples of several aspects of innate immunity that are conserved
among evolutionarily distant species. On the other hand, C. elegans in-
nate immunity does not have components of the Toll pathway that
are essential in mammals and insects like Drosophila, such as the pro-
teins MyD88 and NF-kB [31]. In another study, researchers used
quantitative proteomics to investigate aspects of C. elegans immune
response to pathogens and proved that the intracellular ferritin ho-
mologue FTN-2 is essential for the nematode's defense against bacte-
ria [35,36].
C. elegans has proved to be an essential model for the study of fungal
virulence and for the identiﬁcation of novel antifungal compounds. The
nematodewas used in many studies to evaluate the virulence factors of
C. albicans. Speciﬁcally Pukkila-Worley et al., showed that hyphal for-
mation plays an important role in C. albicans virulence against C. elegans
and that mutant strains of the fungus that are unable to form spores
have decreased virulence [37]. In addition, a later study by the same
investigators dissected the immune response of nematodes to patho-
genic fungi [38]. Furthermore, co-infection models of C. elegans with
C. albicans and prokaryotic organisms such as Acinetobacter baumannii
[39], and Salmonella enterica [40] showed that prokaryotes are able to
inhibit ﬁlamentation of C. albicans in the nematode and that this inhibi-
tion is caused, at least in part, by some kind of secreted substance by the
bacterium, thus providing a potential path for the discovery of new an-
tifungal agents. Interestingly, with co-infection of A. baumannii the
nematodes had extended survival compared to C. albicans infection
alone. A more recent study [41] extended these ﬁndings to include
Enterococcus faecalis in the group of prokaryotes that can negatively af-
fect C. albicans virulence and hyphal formation in C. elegans mainly
through an unidentiﬁed substance secreted by the bacterium. Finally,
studies on virulence factors using C. elegans infection assays have been
developed for fungi other than Candida, including C. neoformans [42]
and Histoplasma capsulatum [43].
C. elegans infection assays can also be used as a screening method
for potential antifungal compounds. For example, Breger et al.
screened 1266 compounds and identiﬁed 15 that prolonged survival
in C. albicans-infected nematodes, two of which proved effective in a
murine model of candidiasis, thus validating the method [44]. Soon
thereafter, another study identiﬁed 12 saponins out of 2560 natural
products that increased survival of C. albicans-infected C. elegans [45].
Of note, the deacetylated version of one of the saponins identiﬁed in
this study, also known as gliotoxin, is produced by A. fumigatus and, in
a later study, was found to improve survival in Candida-infected nema-
todes [46]. Another screen of 3228 bioactive compounds yielded 19
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tion with C. albicans, including most known antifungal compounds
within the chemical library [47]. Finally, a newer study [48] found that
the bacterial signaling molecule indole and its derivative indole-3-
acetonitrile (IAN) attenuate C. albicans virulence in vivo via regulation
of NGR-1, a transcription factor that affects fungal bioﬁlm formation
and ﬁlamentation.
In summary, the advantages of the model are that it can be used to
screen a wide variety of compounds using automatic methods in liq-
uid medium and, because it is an in vivomodel, it can provide insight
into the toxicity of some of the compounds that may have in vitro ef-
ﬁcacy against fungi. However, given the simplicity of the nematode
immune system compared to the mammalian, the model may fail to
identify some substances that may have an immunomodulatory effect
that confers protection against pathogenic infection in humans.
4. Galleria mellonella
The larvae of the greater waxmoth, G. mellonella, ﬁrst used to study
entomopathogenic fungi [49], soon thereafter proved to be an excellent
model for studying human fungal infections. In 2000, Cotter et al.
showed that G. mellonella larvae can be killed by C. albicans but not by
Saccharomyces cerevisiae [50], and this model system has since become
ever more popular for the study of fungal pathogenesis. The main ad-
vantages of the model are that the larvae are easy to obtain, do not
need special lab equipment and, most importantly and in contrast to
the models previously described, G. mellonella larvae can grow at
37 °C, making them ideal for the study of interactions and fungal viru-
lence factors that may only be present at this temperature. Of note,
however, is that incubation of the larvae at this temperature enhances
its immune response to pathogens [51,52]. A further advantage is that,
compared to other mini-host models, G. mellonella larvae are signiﬁ-
cantly larger, which facilitates direct injection of an inoculumwith a sy-
ringe without signiﬁcantly traumatizing the insect, permitting the
administration of a speciﬁc amount of a pathogen [53]. On the other
hand, the limitations of the model compared to the aforementioned
model hosts are that G. mellonella does not have a fully sequenced ge-
nome (although a comprehensive transcriptome of genes that partici-
pate in its immune response has been identiﬁed recently [54]) and
there is no established method of creating mutant strains.
The innate immune system of G. mellonella consists of both cellular
and humoral components. More speciﬁcally, the cellular immune re-
sponse is orchestrated by six different hemocytes (prohemocytes,
coagulocytes, spherulocytes, oenocytoids, plasmacytes and granulocytes)
and its main antimicrobial process is phagocytosis. The relevance of the
model for the investigation of human immune responses was illustrated
by the discovery of homologues to the human proteins p47phox and
p67phox, which participate in the NADPH oxidase system. These homo-
logues translocate to the cellmembrane in activated hemocytes of the in-
sect and are inhibited by the gliotoxin [55] and fumagilin [56] produced
by A. fumigatus. Moreover, as in other insect models, pattern recognition
molecules seem to play a very important role in theG.mellonella immune
response. For example, apolipophorin III is a pattern recognition mole-
cule that has been shown to recognize and bind to β-1,3-glucans of
C. albicans fungi and to help in their elimination from the hemolymph
of the insect through a process called nodulation [57], and it was also
shown that apolipophorin III has a close resemblance to the N-terminal
domain of the human protein ApoE [58]. Apart from the cellular
response, the larvae seem to mount an additional humoral immune re-
sponse to pathogenic fungi that seems to be different from the response
against bacterial pathogens [59]. Although the speciﬁc pathways of this
humoral immune response are as-yet unidentiﬁed, their ﬁnal result is
the secretion of antimicrobial peptides amongwhich two antifungal pep-
tides (gallerimycin and galiomicin) have been identiﬁed. The former was
found to be active against the entomopathogenic fungus Metarhizium
anisopliae, but not against yeast, Gram-negative and Gram-positivebacteria [60], while the latter was induced after exposure to the patho-
genic fungus Beauveria bassiana [48]. Moreover, pre-exposure to a
nonlethal dose of yeast made the larvae more resistant to a subsequent
exposure to a lethal dose of C. albicans and this resistance was mainly
mediated by the over production of antimicrobial peptides including
gallerimycin, galiomicin, transferrin, and an inducible metalloproteinase
inhibitor [61]. Finally, Fallon et al. showed that, following inoculation
with A. fumigatus conidia, G. mellonella larvae were able to differentially
activate cellular or humoral immune responses depending on the size
of the inoculum [62]. Interestingly, environmental factors can also have
various impacts on G. mellonella immunity. For example, as mentioned
above, pre-exposure of larvae to heat induces their immune response
[51,52], while nutrient deprivation leads to reduction of their cellular
and humoral immune response, thus increasing susceptibility to infec-
tion [63]. Therefore, these inﬂuences need to be taken into account
when conducting experiments on G. mellonella larvae in order to allow
comparisons to be made between results from different laboratories.
As mentioned above, G. mellonella larvae are susceptible to killing
by C. albicans [50] and ﬁlamentation played a role in its virulence [64]
but was not sufﬁcient on its own to kill the insects [65], suggesting
that other as-yet unidentiﬁed virulence traits contribute to the path-
ogenesis. Another study indicated that G. mellonella is susceptible to
C. neoformans infection and can serve as a model to study its virulence
factors. Speciﬁcally, it was shown that capsule formation and melanin
production were important factors in the virulence of C. neoformans
in the invertebrate, results which are in concordance with murine
and mammalian models, thus validating the model [66]. Morpholog-
ical changes, such as capsule enlargement, that occur in C. neoformans
cells during infection in mammals have also been observed during the
course of G. mellonella infection by the same pathogen [67]. Addition-
ally, G. mellonella larvae have been used to investigate the virulence
factors of members of the fungal genus Fusarium, proving that conid-
ial morphology and incubation temperatures are both important de-
terminants of outcome in this kind of infection [68]. This model was
expandedmore recently to investigate the virulence of mutant strains
of A. fumigatus and the results correlated well with previous results in
mice [69]. On the other hand, previous reports have shown that mel-
anization of A. fumigatus conidia, an important virulence factor in
mammals, is not important for infection in the lepidopteran model
with melanization-defective conidia showing even greater killing
effect than wild-type conidia, thus exposing a potential limitation
of the model [70]. Finally, a recent study provided evidence that
G. mellonella could be a useful model for the study of dimorphic
fungi, by showing that H. capsulatum and Paraoccidioides lutzii are
able to kill the larvae both at 25 °C and at 37 °C [71].
In a previously mentioned study [66], the researchers tested the ef-
fects of ﬂuconazole, ﬂucytosine and amphotericin B on the survival of
the larvae in the G. mellonella–C. neoformans infection model and
found that survival was greatest with the combination of amphotericin
B and ﬂucytosine, a result which agrees with previous studies on mice
and humans, thus proving that G. mellonella is an excellent model host
for the screening of the efﬁcacy of new antifungal compounds. In accor-
dance with these ﬁndings, different researchers showed that the anti-
fungals amphotericin B, ﬂuconazole, voriconazole and caspofungin at
therapeutic doses can have a protective effect on G. mellonella larvae
against Candida tropicalis [72]. In another recent study, astemizole and
a related analog (A2) were found to be active against Cryptococcus spe-
cies in combination with ﬂuconazole in the same in vivomodel [73]. In
addition, another study found that the immunosuppressant rapamycin
was able to promote survival by 50% in insects infected with the
zygomycete Mucor circinelloides [74]. Interestingly, G. mellonella can
also identify compounds that, apart from their antifungal activity, also
exert an immunomodulatory effect in the host; for example, the drug
caspofungin was shown to increase survival of C. albicans-infected
G. mellonella both by its antifungal properties and by enhancing the
insect's immune response [75].
Table 1
Examples of fungal virulence factors studied in invertebrates.
Drosophila melanogaster Caenorhabditis elegans Galleria mellonella Bombyx mori Amoebae
Candida albicans Filamentation [20] Filamentation [37] Filamentation [64] Hyphal growth,
proteolysisa [81]
NAb
Cryptococcus neoformans Polysaccharide capsule
formation not necessary [21]
Polysaccharide capsule,
laccasec, α allele of the
mating type locus [42]
Polysaccharide capsule,
melanin [66]
NAb Polysaccharide
capsule [76,77]
Aspergillus fumigatus Gliotoxin, melanin [84] NAb Hydroxamate-type siderophores,
PABAd biosynthesis, cross-pathway
control mechanism [69]
NAb NAb
Blastomyces dermatitidis NAb NAb NAb NAb Ability to adhere
to host cells [79]
a Via the putative C. albicans protein dephosphorylation gene PTC1.
b Not available.
c Enzyme essential for melanin production.
d para-Aminobenzoic acid.
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host for the study of fungal virulence in human body temperatures
and for the detection of novel antifungal compounds. However, the
fact that its genome is not yet fully sequenced limits its application
in the study of the innate immunity.
5. Other invertebrate model hosts
In addition to the three main invertebrate models previously men-
tioned, several other mini-hosts have been used as models to study
different features of the pathogenesis of fungal diseases. For example,
soil-living amoebae are excellent model hosts for the study of phago-
cytosis. Studies have shown that Acanthamoeba castellanii can phago-
cytose C. neoformans, S. cerevisiae and C. albicans in a similar manner
as macrophages and that virulence traits important against mammals,
like the capsule of C. neoformans, are also important for protection
against killing by the amoeba [76,77]. In a study of C. neoformans–
A. castellanii interactions, capsular enlargement of the fungal cells
and nonlytic exocytosis of phagocytosed cells from the amoeba
were observed. These processes, which are similar to the interactions
between C. neoformans and mammalian macrophages, show that the
amoeba is a promising model for studying the interactions between
macrophages and facultatively intracellular pathogens [77]. Further
study of these interactions led to the discovery that phospholipids
maybe the triggers for capsular enlargement in C. neoformans cells in re-
sponse to phagocytosis both by amoebae andmammalianmacrophages
[78]. Moreover, the same researchers found that dimorphic fungi like
Blastomyces dermatitidis, Sporothrix schenckii and H. capsulatum can be
phagocytosed in their yeast form by A. castellanii and, interestingly, ex-
posure of an avirulent laboratory strain of H. capsulatum to A. castellanii
induced a phenotype of H. capsulatum that caused a persistent lung in-
fection inmice [79], suggesting that virulence traits of fungi that are im-
portant against mammals may have been developed through the
process of natural selection by the interaction of these fungi with amoe-
boid predators. The same conclusion was reached after a similar study
that showed increased virulence of C. neoformans after its passage
through cultures of Dictyostelium discoideum, another soil amoeba [80].
Different researchers used the silkworm Bombyx mori to identify
important virulence traits of C. albicans [81]. After validating the
model by proving that mutant strains of C. albicans previously
shown to have attenuated virulence in mice also had decreased viru-
lence in the silkworm, the study found that the protein phosphatase
gene PTC1 contributes to the virulence of the fungus. The model
was further validated by a different experiment in which researchers,
using silkworms infected with mutant strains of C. glabrata, identiﬁed
the gene CYB2 encoding lactate dehydrogenase as an important factor
for C. glabrata survival in the intestine [82]. Finally, the mosquito
Culex quinquefasciatus has been used as a model to study the cellular
immune response against yeast cells [83].6. Conclusions
The study of invertebrate hosts is a rapidly growing area of inter-
est for many researchers in the ﬁeld of mycology. Several fungal viru-
lence traits have been studied (Table 1), and potential antifungal
compounds have been identiﬁed using these hosts. The choice of
one model host over another depends mainly on the purpose of the
speciﬁc study. For example, cellular immune responses such as
phagocytosis can be easily studied using amoebae or G. mellonella as
hosts, whereas D. melanogaster is an excellent model host for study-
ing evolutionarily preserved complex innate immune pathways
against fungal pathogens, and C. elegans is a very promising model
for the rapid screening of potential antifungal compounds as well as
for the identiﬁcation of important fungal virulence traits. However,
due to their limitations, these model hosts cannot completely replace
mammalian models in fungal experimentation. Instead, they should
serve as an additional, easy to use, rapid screening method to expand
our knowledge of the exciting world of fungal pathogenesis and to
serve as new weapons in the ﬁght against fungal pathogens.References
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